BMC Endocrine Disorders

BMC Endocrine Disorders is a peer-reviewed, open access journal published by Springer Nature as part of the BMC series. With an ISSN of 1472-6823 and a 2026 Impact Factor of 3.2630, the journal is currently ranked in the third quartile (Q3) of the JCR category for Endocrinology & Metabolism. The journal’s scope encompasses all aspects of the prevention, diagnosis, and management of endocrine and metabolic disorders, including but not limited to diabetes mellitus, thyroid diseases, adrenal and pituitary disorders, bone and mineral metabolism, obesity, lipid disorders, and reproductive endocrinology. It welcomes original research articles, reviews, clinical trials, study protocols, case reports, and database analyses that contribute meaningful evidence to the field. The target audience includes endocrinologists, diabetologists, general physicians, clinical researchers, epidemiologists, and public health professionals. A notable feature of BMC Endocrine Disorders is its fully open access model, which ensures that all published content is freely and permanently available online, promoting wide dissemination and high visibility. As part of the BMC family, the journal adheres to rigorous peer review and ethical standards, emphasizing methodological soundness and scientific validity over perceived novelty. While its Q3 quartile placement and moderate impact factor indicate a competitive but not top-tier standing within the specialized field of endocrinology, the journal serves as a valuable platform for disseminating clinically relevant and reproducible research, particularly for studies from diverse global settings and underrepresented populations.